Associations between common genetic polymorphisms in the liver X receptor alpha and its target genes with the serum HDL-cholesterol concentration in adolescents of the HELENA Study

Atherosclerosis

Volumn 216, Issue 1, 2011, Pages 166-169

  Legry, Vanessa ^a   Bokor, Szilvia ^a   Beghin, Laurent ^a,b   Galfo, Myriam ^c   Gonzalez Gross, Marcela ^d   Molnar, Denes ^e   Moreno, Luis A ^f   Amouyel, Philippe ^a   Dallongeville, Jean ^a   Meirhaeghe, Aline ^a  

^a UNIV LILLE   (France)

^b University of Lille   (France)

^c ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

^d UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^e UNIVERSITY OF PÉCS   (Hungary)

^f UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

ABCA1; Adolescents; Association study; HDL cholesterol; Lipid; LXR alpha; Polymorphism

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN E; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LIVER X RECEPTOR; NUCLEAR PROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; PROTEIN NR1H3; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BODY MASS; FEMALE; GENE FREQUENCY; GENE TARGETING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79955526840     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.01.031     Document Type: Article

References (15)

1. Kwiterovich P.O. The antiatherogenic role of high-density lipoprotein cholesterol. Am J Cardiol 1998, 82:13Q-21Q.
2. Williams C.L., Hayman L.L., Daniels S.R., et al. Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2002, 106:143-160.
3. Zhao C., Dahlman-Wright K. Liver X receptor in cholesterol metabolism. J Endocrinol 2010, 204:233-240.
4. Willy P.J., Umesono K., Ong E.S., et al. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 1995, 9:1033-1045.
5. Robitaille J., Houde A., Lemieux S., et al. The lipoprotein/lipid profile is modulated by a gene-diet interaction effect between polymorphisms in the liver X receptor-alpha and dietary cholesterol intake in French-Canadians. Br J Nutr 2007, 97:11-18.
6. Legry V., Cottel D., Ferrieres J., et al. Association between liver X receptor alpha gene polymorphisms and risk of metabolic syndrome in French populations. Int J Obes (Lond) 2008, 32:421-428.
7. Sabatti C., Service S.K., Hartikainen A.L., et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 2009, 41:35-46.
8. Teslovich T.M., Musunuru K., Smith A.V., et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466:707-713.
9. Moreno L.A., de Henauw S., Gonzalez-Gross M., et al. Design and implementation of the Healthy Lifestyle in Europe by Nutrition in Adolescence Cross-Sectional Study. Int J Obes (Lond) 2008, 32(Suppl 5):S4-S11.
10. Ruiz J.R., Labayen I., Ortega F.B., et al. Attenuation of the effect of the FTO rs9939609 polymorphism on total and central body fat by physical activity in adolescents: the HELENA study. Arch Pediatr Adolesc Med 2010, 164:328-333.
11. Gonzalez-Gross M., Breidenassel C., Gomez-Martinez S., et al. Sampling and processing of fresh blood samples within a European multicenter nutritional study: evaluation of biomarker stability during transport and storage. Int J Obes (Lond) 2008, 32Suppl5:S66-S75.
12. Barrett J.C., Fry B., Maller J., Daly M.J., Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
13. Gauderman WJ, Morrison JM. QUANTO 1.1: a computer program for power and sample size calculations for genetic-epidemiology studies. http://hydra usc edu/gxe; 2006.
14. Vergeer M., Boekholdt S.M., Sandhu M.S., et al. Genetic variation at the phospholipid transfer protein locus affects its activity and high-density lipoprotein size and is a novel marker of cardiovascular disease susceptibility. Circulation 2010, 122:470-477.
15. Chasman D.I., Pare G., Mora S., et al. Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLoS Genet 2009, 5:e1000730.